X-ray powder diffraction data for nicotine 3,5-dihydroxybenzoate dihydrate, C 10 H 15 N 2 ⋅C 7 H 5 O 4 ⋅2H 2 O
Source abstract
Abstract
Nicotine 3,5-dihydroxybenzoate dihydrate is a nicotine salt and can be used as compositions in tobacco products. X-ray powder diffraction data, unit-cell parameters, and space group for nicotine 3,5-dihydroxybenzoate, C 10 H 15 N 2 ⋅C 7 H 5 O 4 ⋅2H 2 O, are reported [ a = 8.424(1) Å, b = 13.179(8) Å, c = 8.591(1) Å, α = 90°, β = 102.073(8)°, γ = 90°, unit-cell volume V = 932.765(3) Å 3 , Z = 2, ρ cal = 1.256 g⋅cm −3 , and space group P 2 1 ] at room temperature. All measured lines were indexed and are consistent with the P 2 1 space group.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (9)
Show source-provided references
1. Dull, G. M. , Car, A. , and Sharp, E. (2015). “Nicotine salts, co-crytals, and salt co-crystal complexes,” Patent No.: WO2015183801A1.
2. 10.1107/S002188988100961810.1107/S0021889881009618 ↗
3. 10.1107/S010876730704393010.1107/S0108767307043930 ↗
4. 10.1107/S002188980202334810.1107/S0021889802023348 ↗
5. Dull, G. M. , Carr, A. , and Sharp, E. (2017). “Nicotine salts, co-crytals, and salt co-crystal complexes,” Patent No.: US9738622B2.
6. Crystal structure refinement with SHELXL
7. 10.1107/S002188980804272610.1107/S0021889808042726 ↗
8. 10.1016/S0079-6468(08)70442-910.1016/S0079-6468(08)70442-9 ↗
9. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers10.1007/s11739-019-02025-3 ↗